Flagship Harbor Advisors’s Nuvation Bio NUVB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,500
Closed -$22.4K 1680
2025
Q4
$22.4K Buy
+2,500
New +$15.5K ﹤0.01% 1295

Other funds holding NUVB

Flagship Harbor Advisors's NUVB Position: Q1 2026 in Review

Flagship Harbor Advisors sold out of Nuvation Bio (NUVB) in Q1 2026, closing a stake of 2,500 shares — an estimated $22.4K sold.

Flagship Harbor Advisors first reported a position in NUVB in Q4 2025 and held it in 1 quarter. The position peaked at $22.4K in Q4 2025. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • Flagship Harbor Advisors reported no remaining Nuvation Bio position as of Q1 2026 after selling out during the quarter.
  • Flagship Harbor Advisors sold 2,500 Nuvation Bio shares in Q1 2026, an estimated $22.4K.
  • Flagship Harbor Advisors first reported a position in Nuvation Bio in Q4 2025 and held it in 1 quarter.
  • Flagship Harbor Advisors's Nuvation Bio position peaked at $22.4K in Q4 2025.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on Flagship Harbor Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.